[ASAP] Discovery of VU2957 (Valiglurax): An mGlu < sub > 4 < /sub > Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson ’s Disease

ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.8b00426

Source: ACS Medicinal Chemistry Letters - October 17, 2018 Category: Chemistry Authors: Joseph D. Panarese, Darren W. Engers, Yong-Jin Wu, Joanne J. Bronson, John E. Macor, Aspen Chun, Alice L. Rodriguez, Andrew S. Felts, Julie L. Engers, Matthew T. Loch, Kyle A. Emmitte, Arlindo L. Castelhano, Michael J. Kates, Michael A. Nader, Carrie K. J Source Type: research